David Fitzpatrick

Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study)

Kenneth G. Saag, David Fitzpatrick, Jeff Kopicko et al. · Arthritis & Rheumatology · 2016 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

María J. Redondo, Susan Geyer, Andrea K. Steck et al. · Diabetes Care · 2018 · 169 citations · Full text

Life Sciences, Endocrinology, Genetics +17

An open-label, 6-month study of allopurinol safety in gout: The LASSO study

Michael A. Becker, David Fitzpatrick, Hyon K. Choi et al. · Seminars in Arthritis and Rheumatism · 2015 · 107 citations · Full text

Pharmacy, Pharmacotherapy, Bioavailability +14

Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study

Yan Su, Eliezer Romeu-Bonilla, Athanasia Anagnostou et al. · Human Vaccines & Immunotherapeutics · 2017 · 57 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Operant investigation of mating preference in female rats.

David J. French, David Fitzpatrick, O. Thomas Law · Journal of Comparative and Physiological Psychology · 1972 · 50 citations

Life Sciences, Behavioral Sciences, Psychology +14